Literature DB >> 22092597

Effects of Coxiella burnetii on MAPKinases phosphorylation.

Nicolas Boucherit1, Abdoulaye Oury Barry, Giovanna Mottola, Virginie Trouplin, Christian Capo, Jean-Louis Mege, Eric Ghigo.   

Abstract

Q fever is a disease caused by Coxiella burnetii, an obligate intracellular bacterium. Acute Q fever is characterized by efficient immune response, whereas chronic Q fever is characterized by dysregulated immune response as demonstrated by the lack of granulomas, the failure of C. burnetii to induce lymphoproliferation, and interferon-γ production. The mitogen-activated protein kinase (MAPK) signaling pathway plays crucial roles in innate immune responses and control of bacterial infections. However, its role in Q fever has not been addressed. First, we investigated the activation of MAPKs p38, c-jun N-terminal kinase (JNK) and extracellular signal-regulated kinase (ERK) 1/2 in murine macrophages stimulated with C. burnetii. Coxiella burnetii NM phase I (virulent) and NM phase II (avirulent) induced the activation of JNK and ERK1/2. Avirulent C. burnetii activate p38, whereas C. burnetii did not induce the phosphorylation of p38. Second, the level of p38 activation was studied in Q fever patients. We found that p38 was activated in monocyte-derived macrophages from healthy donors and patients with acute Q fever in response to a potent agonist such as lipopolysaccharide. Interestingly, p38 was not activated in patients with active chronic Q fever and was activated in patients with cured chronic Q fever. These results suggest that the determination of p38 activation may serve as a tool for measuring Q fever activity.
© 2011 Federation of European Microbiological Societies. Published by Blackwell Publishing Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22092597     DOI: 10.1111/j.1574-695X.2011.00852.x

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN: 0928-8244


  6 in total

1.  Analysis of the Caenorhabditis elegans innate immune response to Coxiella burnetii.

Authors:  James M Battisti; Lance A Watson; Myo T Naung; Adam M Drobish; Ekaterina Voronina; Michael F Minnick
Journal:  Innate Immun       Date:  2016-11-24       Impact factor: 2.680

2.  Primary Role for Toll-Like Receptor-Driven Tumor Necrosis Factor Rather than Cytosolic Immune Detection in Restricting Coxiella burnetii Phase II Replication within Mouse Macrophages.

Authors:  William P Bradley; Mark A Boyer; Hieu T Nguyen; L Dillon Birdwell; Janet Yu; Juliana M Ribeiro; Susan R Weiss; Dario S Zamboni; Craig R Roy; Sunny Shin
Journal:  Infect Immun       Date:  2016-03-24       Impact factor: 3.441

3.  Coxiella burnetii lipopolysaccharide blocks p38α-MAPK activation through the disruption of TLR-2 and TLR-4 association.

Authors:  Filippo Conti; Nicolas Boucherit; Veronica Baldassarre; Virginie Trouplin; Rudolf Toman; Giovanna Mottola; Jean-Louis Mege; Eric Ghigo
Journal:  Front Cell Infect Microbiol       Date:  2015-01-06       Impact factor: 5.293

4.  Mechanisms of action of Coxiella burnetii effectors inferred from host-pathogen protein interactions.

Authors:  Anders Wallqvist; Hao Wang; Nela Zavaljevski; Vesna Memišević; Keehwan Kwon; Rembert Pieper; Seesandra V Rajagopala; Jaques Reifman
Journal:  PLoS One       Date:  2017-11-27       Impact factor: 3.240

5.  The Coxiella burnetii T4SS Effector AnkF Is Important for Intracellular Replication.

Authors:  Julian Pechstein; Jan Schulze-Luehrmann; Stephanie Bisle; Franck Cantet; Paul A Beare; Martha Ölke; Matteo Bonazzi; Christian Berens; Anja Lührmann
Journal:  Front Cell Infect Microbiol       Date:  2020-11-13       Impact factor: 5.293

Review 6.  Coxiella burnetii Lipopolysaccharide: What Do We Know?

Authors:  Prasad Abnave; Xavier Muracciole; Eric Ghigo
Journal:  Int J Mol Sci       Date:  2017-11-23       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.